Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 3/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | CES1 | P23141 | 1/20 | 0.45 |
| ▸ | S100A4 | P26447 | 1/20 | 0.41 |
| ▸ | PABPC1 | P11940 | 3/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TYMS | P04818 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31291412 | 0.80 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL4922451 | 0.80 | MAPK1 (0.52) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL9347855 | 0.76 | GPR84 (0.38) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL5430435 | 0.76 | MEN1 (0.61) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL28571360 | 0.76 | MEN1 (0.61) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL779663 | 0.73 | MAPK1 (0.53) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL58539 | 0.72 | MAPK1 (0.57) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL30184802 | 0.72 | MEN1 (1.00) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL16225115 | 0.72 | MEN1 (1.00) | MAPK1MEN1KMT2AMAPTALDH1A1 | |
| SCHEMBL3124182 | 0.72 | MEN1 (0.51) | MAPK1MEN1KMT2AMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11702557-B2 | Ink composition for manufacturing organic semiconductor device | DAICEL CORPORATION (JP) | 2023-07-18 | — | — | US | disclosed |
| EP-3958335-A1 | INK COMPOSITION FOR PRODUCING ORGANIC SEMICONDUCTOR DEVICE | Daicel Corporation (JP) | 2022-02-23 | — | — | EP | disclosed |
| CN-113692653-A | Ink composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2021-11-23 | — | — | CN | disclosed |
| US-20210246325-A1 | INK COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | DAICEL CORPORATION (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3855520-A1 | INK COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | Daicel Corporation (JP) | 2021-07-28 | — | — | EP | disclosed |
| CN-112771684-A | Ink composition for manufacturing organic semiconductor device | 株式会社大赛璐 | 2021-05-07 | — | — | CN | disclosed |
| WO-2020213460-A1 | INK COMPOSITION FOR PRODUCING ORGANIC SEMICONDUCTOR DEVICE | 株式会社ダイセル | 2020-10-22 | — | — | WO | disclosed |
| WO-2020059626-A1 | INK COMPOSITION FOR MANUFACTURING ORGANIC SEMICONDUCTOR DEVICE | 株式会社ダイセル | 2020-03-26 | — | — | WO | disclosed |
| US-9139589-B2 | Heteroaryls and uses thereof | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-9090601-B2 | Thiazole derivatives | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2015-07-28 | — | — | US | disclosed |
| EP-1752457-A1 | FUSED HETEROCYCLIC COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2007-02-14 | — | — | EP | disclosed |
| WO-2007004749-A1 | FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-01-11 | — | — | WO | disclosed |
| EP-1287044-A4 | STERILE PHOTOCHROMIC HYDROPHILIC CONTACT LENSES | NOVARTIS AG (CH) | 2004-12-15 | — | — | EP | disclosed |
| US-20030149027-A1 | 1,5-benzodiazepine compounds, their production and use | OI SATORU (JP) | 2003-08-07 | — | — | US | disclosed |
| EP-1287044-A1 | STERILE PHOTOCHROMIC HYDROPHILIC CONTACT LENSES | Novartis AG (CH) | 2003-03-05 | — | — | EP | disclosed |
| EP-1123928-A1 | 1,5-BENZODIAZEPINE COMPOUNDS, PROCESS FOR PRODUCING THE SAME, AND MEDICINE | Takeda Chemical Industries, Ltd. (JP) | 2001-08-16 | — | — | EP | disclosed |
| WO-2001030866-A1 | STERILE PHOTOCHROMIC HYDROPHILIC CONTACT LENSES | WESLEY JESSEN CORPORATION (US) | 2001-05-03 | — | — | WO | disclosed |
| US-6162828-A | IMMUNOLOGY; ANTIINFLAMMATORY AGENTS; ANTITUMOR AGENTS; BONE DISORDERS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-12-19 | — | — | US | disclosed |
| EP-0820464-A2 | CYSTEINE PROTEASE INHIBITOR | Takeda Chemical Industries, Ltd. (JP) | 1998-01-28 | — | — | EP | disclosed |
| WO-1996030395-A2 | CYSTEINE PROTEASE INHIBITOR | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-10-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149027-A1 | 1,5-benzodiazepine compounds, their production and use | GABRA1, GABRA5, CNR1 | MAPK1 1634/4885MEN1 3395/4885KMT2A 1490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.